ERBB2 and cancer: Hence, we envisioned that simultaneous targeting of liposomes with FAP’scFv and HER2’scFv will potentially impact the HER2’scFv based rapid binding and deliver fluorescent cargos into cancer cells in vivo and enhance their fluorescence detection.